LIFE TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 11 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-08-22: Reporting owner UPRICHARD DAVID C; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-08-22: Reporting owner LUCIER GREGORY T; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-08-11: Reporting owner UPRICHARD DAVID C; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-08-11: Reporting owner UPRICHARD DAVID C; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-08-22 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 3,000 owned after | $31.86 exercise price | 2011-08-24 | |
| 2011-08-22 | LUCIER GREGORY T Officer (Chief Executive Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,232 0 owned after | $32.69 exercise price | 2011-08-24 | |
| 2011-08-11 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −290 3,710 owned after | $31.86 exercise price | 2011-08-15 | |
| 2011-08-11 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −310 3,400 owned after | $31.86 exercise price | 2011-08-15 | |
| 2011-06-07 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 4,000 owned after | $31.86 exercise price | 2011-06-08 | |
| 2011-03-15 | LEVINE ARNOLD J Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,958 0 owned after | $32.17 exercise price | 2011-03-16 | |
| 2011-03-15 | Grossman Paul David Officer (SVP, Corporate Strategy & Dev.) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,556 37,112 owned after | $22.23 exercise price | 2011-03-16 | |
| 2011-03-11 | ADAM GEORGE F JR Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,828 0 owned after | $39.22 exercise price | 2011-03-14 | |
| 2011-01-03 | LORIMIER BRADLEY G Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,339 0 owned after | $33.31 exercise price | 2011-01-04 | |
| 2011-01-03 | LORIMIER BRADLEY G Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,661 8,339 owned after | $33.31 exercise price | 2011-01-04 | |
| 2011-01-03 | Brust Bernd Officer (President, Molecular Medicine) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,750 0 owned after | $28.30 exercise price | 2011-01-04 |